TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8+ T cell function
Modulation or depletion of tumor-infiltrating Tregs (Ti-Tregs) is a promising strategy in the field of antitumor immunotherapy. However, this approach poses challenges due to the diversity within the Treg population and the lack of precision in targeting Ti-Tregs. To selectively and efficiently elim...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2025-12-01
|
| Col·lecció: | OncoImmunology |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2497171 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|